Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October)

Full Issue pdf

Commentary

Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura: Rituximab in TTP

Hasan Tahsin Özpolat, Moritz Stolla
Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies: mAbs versus pAbs against SARS-CoV-2 variants

David McIntosh, Thierry Burnouf, Michael Karbiener, Maria R. Farcet, Thomas R. Kreil

Position paper

Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers: Bioequivalence of rFVIII concentrates

Ezio Zanon, Raimondo De Cristofaro, Massimo Franchini, Massimo Morfini, Gianfranco Pasut, Angelo Claudio Molinari, Cristina Santoro, Rita Carlotta Santoro, Antonio Coppola, Angiola Rocino

Original article

Brief report

Case report

Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens! Solid tumor transmission from donor to recipient

Panagiotis Tsirigotis, Alexandros Spyridonidis, Konstantinos Gkirkas, Spiros Chondropoulos, Phivi Rondogianni, Thomas Thomopoulos, Angeliki Karagiannidou, Dionysios Vythoulkas, Marianna Griniezaki, Nikolaos Georgakopoulos, Maria Stamouli, Periklis G. Foukas

Submit an Article

Announcements

Winter Closure

The Editorial Office will be closed from December 31 to January 7, 2026.

Season’s greetings to all our readers, authors, and reviewers.

SIMTI 2026

46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)

SETS 2026

35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).

Madrid, 4-6 June 2026.

Editorial Office Closure Notice

Please note that the BT Editorial Office will be closed until August 26, 2026.

During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.

Thank you for your understanding.

Best regards,
BT Editorial Office

Impact Factor 2025

We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.

Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October)

Full Issue pdf

Commentary

Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura: Rituximab in TTP

Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies: mAbs versus pAbs against SARS-CoV-2 variants

Position paper

Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers: Bioequivalence of rFVIII concentrates

Original article

When the available blood supply mismatches the needs of the patient: Mismatches between blood supply and patient needs

Red blood cell alloantibodies in the context of critical bleeding and massive transfusion: Red cell alloantibodies in critical bleeding massive transfusion

Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPTtm Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience: Efficiency of pathogen-reduced platelet transfusion

Lipidomic analysis of differently prepared platelet concentrates in additive solution during storage: Lipidomic of transfusion-dedicated platelet concentrate

Dissecting the complexity of pediatric blood transfusions and risk of adverse reactions in Aotearoa New Zealand: Pediatric transfusions and adverse reaction risk in NZ

Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features: Autoimmunity and steroids in MDS

Brief report

Identification of an Alu-mediated 5.7-kb deletion of the LU gene in a pregnant Moroccan woman with anti-Lu3: Novel silent LU (D3-8) allele

Superoxide measurement as a novel probe of red blood cell storage quality: Red blood cell superoxide generation

Case report

Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens! Solid tumor transmission from donor to recipient

Announcements

Winter Closure

SIMTI 2026

SETS 2026

Editorial Office Closure Notice

Impact Factor 2025

Information

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October)

Full Issue pdf

Commentary

Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura: Rituximab in TTP

Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies: mAbs versus pAbs against SARS-CoV-2 variants

Position paper

Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers: Bioequivalence of rFVIII concentrates

Original article

When the available blood supply mismatches the needs of the patient: Mismatches between blood supply and patient needs

Red blood cell alloantibodies in the context of critical bleeding and massive transfusion: Red cell alloantibodies in critical bleeding massive transfusion

Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPTtm Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience: Efficiency of pathogen-reduced platelet transfusion

Lipidomic analysis of differently prepared platelet concentrates in additive solution during storage: Lipidomic of transfusion-dedicated platelet concentrate

Dissecting the complexity of pediatric blood transfusions and risk of adverse reactions in Aotearoa New Zealand: Pediatric transfusions and adverse reaction risk in NZ

Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features: Autoimmunity and steroids in MDS

Brief report

Identification of an Alu-mediated 5.7-kb deletion of the LU gene in a pregnant Moroccan woman with anti-Lu3: Novel silent LU (D3-8) allele

Superoxide measurement as a novel probe of red blood cell storage quality: Red blood cell superoxide generation

Case report

Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens! Solid tumor transmission from donor to recipient

Announcements

Winter Closure

SIMTI 2026

SETS 2026

Editorial Office Closure Notice

Impact Factor 2025

Information

Banner